As for ovarian cancer patients, K-PD modeling was able to characterize the longitudinal PSA dynamics during treatment based on PSA production KPROD, PSA elimination KELIM, and indirect treatment effect on patients, independent of the selected time points used to calculate it. The gene discussed is KLK3; the disease is ovarian carcinoma.